|
Nov 4
|
Company News for Nov 4, 2024
|
|
Nov 4
|
Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?
|
|
Nov 2
|
Cardinal Health Inc (CAH) Q1 2025 Earnings Call Highlights: Strong Pharma Segment Profit Growth ...
|
|
Nov 1
|
Sector Update: Health Care Stocks Rise Late Afternoon
|
|
Nov 1
|
Cardinal Health Revenue Jumps on Wider Use of Obesity Drugs
|
|
Nov 1
|
Cardinal Health Stock Hits All-Time High as Existing Customers Power Results
|
|
Nov 1
|
Cardinal Health Lifts 2025 Earnings Guidance Following First-Quarter Beat; Shares Rise Intraday
|
|
Nov 1
|
CAH Stocks Gains on Q1 Earnings & Sales Beat and Raised '25 EPS View
|
|
Nov 1
|
Here's What Key Metrics Tell Us About Cardinal (CAH) Q1 Earnings
|
|
Nov 1
|
Cardinal Health Raises 2025 Profit Outlook Again, Helped By Strong Drug Distribution Business
|
|
Nov 1
|
Cardinal Health (CAH) Q1 Earnings and Revenues Beat Estimates
|
|
Nov 1
|
Cardinal: Fiscal Q1 Earnings Snapshot
|
|
Nov 1
|
Cardinal Health Reports First Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook
|
|
Oct 11
|
Q3 2024 T2 Biosystems Inc Earnings Call
|
|
Oct 11
|
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...
|
|
Oct 9
|
CAH Stock May Gain Following the Distribution Deal With T2 Biosystems
|
|
Oct 7
|
Cardinal Health (CAH) Stock Moves -0.2%: What You Should Know
|
|
Oct 7
|
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
|
|
Oct 7
|
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
|
|
Sep 27
|
Why Drug Distributors Are Buying Cancer Specialists
|